\-\ Texto\\:\\ \ \(0\)\
\-\ ca19\\-9\\:\\ \\ 1164\\ \\(0\\-36\\)\\ \\ \\ \\ \\ \\ \\ \\ u\\/ml\\ \\ \ \(0\)\
\-\ afp\\:\\ \\ \\ \\ \\ 1\\.7\\ \\ \\(0\\.0\\-15\\.0\\)\\ \\ \\ \\ ng\\/ml\\ \\ \\ \\ \\ \ \(0\)\
\-\ cea\\ \\ \\ \\ \\ \\ 7\\.9\\ \\ \\(0\\.0\\-4\\.6\\)\\ \\ \\ \\ \\ ng\\/ml\ \(0\)\
\-\ imaging\\ guided\\ biopsy\\ of\\ the\\ lesion\\ was\\ considered\\,\\ and\\ declined\\ secondary\\ to\\ inaccessibility\\.\\ \\ patient\\ will\\ decide\\ whether\\ to\\ undergo\\ laproscopy\\.\ \(0\)\
\-\ hypodense\\ lesion\\ in\\ the\\ tail\\ of\\ the\\ pancreas\\,\\ with\\ cystic\\ and\\ soft\\ tissue\\ components\\.\\ \\ minimal\\ pancreatic\\ duct\\ dilatation\\.\\ there\\ were\\ no\\ hepatic\\ lesions\\,\\ and\\ all\\ mesenteric\\ and\\ retroperiteoneal\\ nodes\\ were\\ sub\\-centimeter\\.\ \(0\)\
\-\ mucinous\\ cystic\\ neoplasm\\ of\\ the\\ pancreas\ \(0\)\
\-\ mucinous\\ cystadenoma\\/cystadenocarcinoma\ \(0\)\
\-\ intraductal\\ papillary\\ tumor\ \(0\)\
\-\ atypical\\ pseudocyst\ \(0\)\
\-\ patient\\ recently\\ had\\ surgical\\ repair\\ of\\ left\\ inguinal\\ hernia\\.\\ \\ pathology\\ on\\ the\\ sac\\ and\\ surrounding\\ soft\\ tissue\\ came\\ back\\ as\\ \\"metastatic\\ adenocarcinoma\\ \\"\\.\\ \\ patient\\ is\\ otherwise\\ healthy\\ and\\ asymptomatic\\.\\ \\ ct\\ was\\ performed\\ in\\ a\\ search\\ for\\ primary\\ malignancy\\.\ \(0\)\
\-\ finding\\ of\\ such\\ markedly\\ increased\\ ca\\ 19\\-9\\,\\ along\\ with\\ pathologic\\ evidence\\ of\\ metastatic\\ disease\\ nearly\\ seal\\ the\\ diagnosis\\.\\ \\ the\\ mucinous\\ cystic\\ pancreas\\ tumors\\ favor\\ the\\ tail\\.\\ \\ \\ ductal\\ neoplasms\\ tend\\ to\\ favor\\ the\\ head\\ and\\ body\\,\\ and\\ contain\\ more\\ soft\\ tissue\\ component\\.\\ \\ imaging\\ features\\ in\\ this\\ case\\ are\\ highly\\ suggestive\\ of\\ the\\ diagnosis\\.\\ there\\ is\\ no\\ surrounding\\ inflammation\\ to\\ suggest\\ pseudocyst\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mucinous\\:\\ 0\\.07613820252256279\ \(0\)\
\-\ pancreas\\:\\ 0\\.06494357179420071\ \(0\)\
\-\ favor\\:\\ 0\\.05812949945346592\ \(0\)\
\-\ ng\\/ml\\:\\ 0\\.056237863445914346\ \(0\)\
\-\ pseudocyst\\:\\ 0\\.05465031245507098\ \(0\)\
\-\ tail\\:\\ 0\\.04658063920587314\ \(0\)\
\-\ ca19\\-9\\:\\ 0\\.043641180316665834\ \(0\)\
\-\ 1164\\:\\ 0\\.043641180316665834\ \(0\)\
\-\ inaccessibility\\:\\ 0\\.043641180316665834\ \(0\)\
\-\ retroperiteoneal\\:\\ 0\\.043641180316665834\ \(0\)\
\-\ 0\\-36\\:\\ 0\\.04020975863072551\ \(0\)\
\-\ 0\\.0\\-15\\.0\\:\\ 0\\.04020975863072551\ \(0\)\
\-\ 0\\.0\\-4\\.6\\:\\ 0\\.04020975863072551\ \(0\)\
\-\ laproscopy\\:\\ 0\\.04020975863072551\ \(0\)\
\-\ seal\\:\\ 0\\.038202505620289054\ \(0\)\
\-\ cystic\\:\\ 0\\.03660345604829344\ \(0\)\
\-\ 7\\.9\\:\\ 0\\.03567366589867524\ \(0\)\
\-\ 19\\-9\\:\\ 0\\.03567366589867524\ \(0\)\
\-\ sub\\-centimeter\\:\\ 0\\.03400796175698607\ \(0\)\
\-\ cystadenoma\\/cystadenocarcinoma\\:\\ 0\\.03400796175698607\ \(0\)\
\-\ u\\/ml\\:\\ 0\\.03334691525884486\ \(0\)\
\-\ decide\\:\\ 0\\.03334691525884486\ \(0\)\
\-\ soft\\:\\ 0\\.030904852930597276\ \(0\)\
\-\ cea\\:\\ 0\\.03057654007104574\ \(0\)\
\-\ tissue\\:\\ 0\\.030080512699790993\ \(0\)\
\-\ declined\\:\\ 0\\.02906474972673296\ \(0\)\
\-\ came\\:\\ 0\\.02881082252679459\ \(0\)\
\-\ intraductal\\:\\ 0\\.028118931722957173\ \(0\)\
\-\ surrounding\\:\\ 0\\.027813517468958073\ \(0\)\
\-\ search\\:\\ 0\\.027511989534381266\ \(0\)\
\-\ 1\\.7\\:\\ 0\\.026641243660798772\ \(0\)\
\-\ afp\\:\\ 0\\.02604044733899547\ \(0\)\
\-\ guided\\:\\ 0\\.025765349065951848\ \(0\)\
\-\ tend\\:\\ 0\\.02398626985353652\ \(0\)\
\-\ inguinal\\:\\ 0\\.02380289722145558\ \(0\)\
\-\ contain\\:\\ 0\\.02337214783041781\ \(0\)\
\-\ nearly\\:\\ 0\\.02329031960293657\ \(0\)\
\-\ whether\\:\\ 0\\.022752528310843522\ \(0\)\
\-\ hypodense\\:\\ 0\\.02253880468774843\ \(0\)\
\-\ neoplasms\\:\\ 0\\.02153272428372235\ \(0\)\
\-\ undergo\\:\\ 0\\.021476146581625204\ \(0\)\
\-\ papillary\\:\\ 0\\.021476146581625204\ \(0\)\
\-\ metastatic\\:\\ 0\\.02129811290709\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.020793416214176408\ \(0\)\
\-\ components\\:\\ 0\\.020745275300407064\ \(0\)\
\-\ pancreatic\\:\\ 0\\.020696977404637933\ \(0\)\
\-\ sac\\:\\ 0\\.020508364304478176\ \(0\)\
\-\ highly\\:\\ 0\\.020371475535515257\ \(0\)\
\-\ markedly\\:\\ 0\\.020023929700499175\ \(0\)\
\-\ ductal\\:\\ 0\\.019940726144477488\ \(0\)\
\-\ imaging\\:\\ 0\\.01982251311342181\ \(0\)\
\-\ recently\\:\\ 0\\.019738637062694048\ \(0\)\
\-\ ca\\:\\ 0\\.01969919067829218\ \(0\)\
\-\ mesenteric\\:\\ 0\\.019506540102798748\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01942791416614277\ \(0\)\
\-\ duct\\:\\ 0\\.01939444863374053\ \(0\)\
\-\ component\\:\\ 0\\.0193211066249032\ \(0\)\
\-\ were\\:\\ 0\\.0192107558088111\ \(0\)\
\-\ nodes\\:\\ 0\\.019107383001808108\ \(0\)\
\-\ healthy\\:\\ 0\\.019072642543101936\ \(0\)\
\-\ hernia\\:\\ 0\\.01851655746897362\ \(0\)\
\-\ pathologic\\:\\ 0\\.01851655746897362\ \(0\)\
\-\ atypical\\:\\ 0\\.018334310077277007\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.018275022002788313\ \(0\)\
\-\ dilatation\\:\\ 0\\.018129835789449104\ \(0\)\
\-\ suggestive\\:\\ 0\\.018072932921004873\ \(0\)\
\-\ suggest\\:\\ 0\\.018016676690062718\ \(0\)\
\-\ inflammation\\:\\ 0\\.01798878650333868\ \(0\)\
\-\ features\\:\\ 0\\.01785164490655979\ \(0\)\
\-\ hepatic\\:\\ 0\\.01766581362280204\ \(0\)\
\-\ pathology\\:\\ 0\\.017313853614466742\ \(0\)\
\-\ lesion\\:\\ 0\\.017233220059410442\ \(0\)\
\-\ considered\\:\\ 0\\.017076942618537854\ \(0\)\
\-\ repair\\:\\ 0\\.016940053849574935\ \(0\)\
\-\ minimal\\:\\ 0\\.016655841437627713\ \(0\)\
\-\ malignancy\\:\\ 0\\.0163469786029778\ \(0\)\
\-\ tumors\\:\\ 0\\.015889684938962877\ \(0\)\
\-\ otherwise\\:\\ 0\\.015194629868447253\ \(0\)\
\-\ biopsy\\:\\ 0\\.015008382384340399\ \(0\)\
\-\ neoplasm\\:\\ 0\\.014406715722336278\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.014299962366317264\ \(0\)\
\-\ along\\:\\ 0\\.013980464736923347\ \(0\)\
\-\ back\\:\\ 0\\.013955773937363749\ \(0\)\
\-\ body\\:\\ 0\\.013738929270738042\ \(0\)\
\-\ finding\\:\\ 0\\.013633967846725156\ \(0\)\
\-\ will\\:\\ 0\\.013235054546431396\ \(0\)\
\-\ such\\:\\ 0\\.013224419751687387\ \(0\)\
\-\ patient\\:\\ 0\\.012721662340342395\ \(0\)\
\-\ there\\:\\ 0\\.012591243133316719\ \(0\)\
\-\ primary\\:\\ 0\\.012531605261859884\ \(0\)\
\-\ head\\:\\ 0\\.011998026289969783\ \(0\)\
\-\ all\\:\\ 0\\.011964967769461836\ \(0\)\
\-\ secondary\\:\\ 0\\.01182688102232083\ \(0\)\
\-\ performed\\:\\ 0\\.011794942233798608\ \(0\)\
\-\ lesions\\:\\ 0\\.011324556962098751\ \(0\)\
\-\ \\:\\:\\ 0\\.011190839762283812\ \(0\)\
\-\ evidence\\:\\ 0\\.011091299917657811\ \(0\)\
\-\ \\(\\:\\ 0\\.010728144449166244\ \(0\)\
\-\ \\)\\:\\ 0\\.010597094437326312\ \(0\)\
\-\ more\\:\\ 0\\.01058008073916914\ \(0\)\
\-\ increased\\:\\ 0\\.010348934563364632\ \(0\)\
\-\ tumor\\:\\ 0\\.009862536146588174\ \(0\)\
\-\ was\\:\\ 0\\.00978492596251175\ \(0\)\
\-\ case\\:\\ 0\\.009254972439936985\ \(0\)\
\-\ had\\:\\ 0\\.009127969402181723\ \(0\)\
\-\ surgical\\:\\ 0\\.00889218698144284\ \(0\)\
\-\ no\\:\\ 0\\.008519249016869327\ \(0\)\
\-\ to\\:\\ 0\\.008456794226593787\ \(0\)\
\-\ and\\:\\ 0\\.007129069533949246\ \(0\)\
\-\ disease\\:\\ 0\\.00691454228324606\ \(0\)\
\-\ the\\:\\ 0\\.006844023995229\ \(0\)\
\-\ \\,\\:\\ 0\\.00670074419597246\ \(0\)\
\-\ as\\:\\ 0\\.006398898544030336\ \(0\)\
\-\ in\\:\\ 0\\.006258374705053291\ \(0\)\
\-\ ct\\:\\ 0\\.00591734481877249\ \(0\)\
\-\ are\\:\\ 0\\.005766702339255454\ \(0\)\
\-\ is\\:\\ 0\\.005567235429551739\ \(0\)\
\-\ this\\:\\ 0\\.0047581050164065995\ \(0\)\
\-\ left\\:\\ 0\\.004733194402341162\ \(0\)\
\-\ of\\:\\ 0\\.004037260423692669\ \(0\)\
\-\ for\\:\\ 0\\.003609446280409481\ \(0\)\
\-\ on\\:\\ 0\\.0035836188730961785\ \(0\)\
\-\ \\.\\:\\ 0\\.0024603638879348907\ \(0\)\
\-\ a\\:\\ 0\\.00196336535553763\ \(0\)\
\-\ with\\:\\ 0\\.0011584571890088094\ \(0\)\
